SB 866 — An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.

Bill Text

• Printer's No. PN1082 View text Current pdf

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

This bill adds medetomidine to the list of controlled substances in Pennsylvania and defines conditions under which it is not considered a controlled substance.

• Section 4(3)

  (xii) Medetomidine, including any compound, mixture or preparation which contains any quantity of the substances referred to in this clause. (xiii) Medetomidine as described in subclause (xii) is not a controlled substance when used in any of the following manners: 1. Dispensing or prescribing for, or administering to, a nonhuman species of a drug containing medetomidine that: (A) has been approved by the United States Secretary of Health and Human Services under 21 U.S.C. § 360b (relating to new animal drugs); or (B) is authorized under 21 U.S.C. § 360b(a)(4). 2. The manufacturing, distribution or use of medetomidine as an active pharmaceutical ingredient for manufacturing an animal drug approved under 21 U.S.C. § 360b or an animal drug that has been issued an investigation use exemption under 21 U.S.C. § 360b(j). 3. The manufacturing, distribution or use of a medetomidine bulk chemical for pharmaceutical compounding by a licensed pharmacist or veterinarians. 4. Any other use approved or authorized under 21 U.S.C. Ch. 9 (relating to Federal Food, Drug, and Cosmetic Act). 5. Another use approved or permissible under Federal or State law.

  This change adds medetomidine as a Schedule III controlled substance while providing specific exemptions for its use in veterinary settings.

• Section 13.9

  A practitioner who is a veterinarian shall comply with the provisions of section 4(a)(5) of the act of September 27, 1961 (P.L.1700, No.699), known as the "Pharmacy Act," for the storage and protection of medetomidine and xylazine.

  This change mandates veterinarians to follow specific regulations for the storage and protection of medetomidine and xylazine.

Action History

1. June 10, 2026

   Referred to Judiciary

2. June 09, 2026

   Third consideration and final passage

3. June 08, 2026

   Re-reported as committed

4. June 03, 2026

   Re-referred to Appropriations

5. June 03, 2026

   Second consideration

6. June 02, 2026

   First consideration

7. June 02, 2026

   Reported as committed

8. July 24, 2025

   Referred to Agriculture & Rural Affairs

Sponsors

• Michele Brooks · Primary
• Doug Mastriano · Cosponsor
• Christine M. Tartaglione · Cosponsor
• Lisa M. Boscola · Cosponsor

Votes

Subjects